Related Business Topics
Latest Headlines
Forbes.com - Nov. 23, 2009, 6:15 PM
revenues. Economic data weigh on Europe as oil prices move past $7 a barrel. Dow Nears 0,000 After hours: Investors gear up for Onyx Pharmaceuticals buys cancer drug developer. Google earnings SEC investigates KB . Asia Update Japanese prime minister ...
Reuters - Nov. 23, 2009, 1:33 PM
THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate® (romiplostim), at a Nov. 18 ceremony in London. The Best Overall ...
CNBC - Nov. 23, 2009, 12:54 PM
Forbes.com - Nov. 23, 2009, 6:09 AM
SAN DIEGO, Calif. 'The strength of the Phase 3 results for Contrave and the Phase 2 results for Empatic(TM) support our belief that these two drug candidates have significant commercial potential,' said Mike Narachi, President and CEO of Orexigen. 'With ...
Reuters - Nov. 23, 2009, 5:55 AM
Seasoned Executives Bring Significant Commercial and Regulatory Experience SAN DIEGO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that four senior executives have joined the organization, ...
Reuters - Nov. 21, 2009, 2:26 AM
(Reuters) - Democrats in the U.S. Senate hope to clear the first procedural hurdle for sweeping healthcare reform on Saturday by voting to open debate on the historic legislation. If the Senate debate goes forward on November 30, it is expected to last ...
Forbes.com - Nov. 20, 2009, 3:32 PM
Retailer says dip may continue. Europe and Asia struggle for gains as Spain remains stuck in recession. HP Buys Com After hours: COM shares Applied Materials and Green Mountain Coffee beat. Chief executive may be ready to Macy's sales tumble. Chinese ...
Reuters - Nov. 20, 2009, 9:46 AM
DUBLIN--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/773f85/strategies_for_bui) has announced the addition of Decision Resources, Inc.'s new report 'Strategies for Building Early-Stage Pharmaceutical Pipelines ...
Forbes.com - Nov. 20, 2009, 9:02 AM
BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/773f85/strategies_for_bui) has announced the addition of Decision Resources, Inc.'s new report 'Strategies for Building Early-Stage Pharmaceutical Pipelines Through External ...
Forbes.com - Nov. 20, 2009, 8:32 AM
(For large-cap stocks on the move, click on) Nov 20 (Reuters) - Some small and midcap stocks on the move on Friday: NOVAVAX INC, $3.35, down 11 pct The company said it is offering 6.8 million common shares at $3.30 per share. SKILLSOFT PLC, $10.45, up 6 ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
A
